Re: Potential Suitor
|
3
|
Resverlogix Corp.
|
Sep 13, 2020 08:33AM
|
Re: Irrational exuberance
|
4
|
Resverlogix Corp.
|
Sep 17, 2020 10:18PM
|
Re: Ground Hog Day
|
7
|
Resverlogix Corp.
|
Sep 18, 2020 03:46PM
|
Re: Proactive Article - new presentation on website
|
|
BIOASIS TECHNOLOGIES INC
|
Sep 21, 2020 07:29AM
|
Re: RVX rises above 200-day moving average
|
1
|
Resverlogix Corp.
|
Sep 21, 2020 02:38PM
|
Re: RVX rises above 200-day moving average
|
5
|
Resverlogix Corp.
|
Sep 21, 2020 05:22PM
|
Re: RVX rises above 200-day moving average
|
2
|
Resverlogix Corp.
|
Sep 21, 2020 06:19PM
|
Re: Hope we have a good day today...
|
6
|
Resverlogix Corp.
|
Sep 21, 2020 06:28PM
|
Re: Don's latest presentation
|
2
|
Resverlogix Corp.
|
Sep 22, 2020 06:57AM
|
Re: Head above water ....
|
5
|
Resverlogix Corp.
|
Sep 22, 2020 10:56AM
|
Re: Head above water ....
|
6
|
Resverlogix Corp.
|
Sep 22, 2020 11:50AM
|
Re: Head above water ....
|
7
|
Resverlogix Corp.
|
Sep 22, 2020 01:26PM
|
Re: Head above water ....
|
7
|
Resverlogix Corp.
|
Sep 22, 2020 02:53PM
|
Re: Proactive Article - new presentation on website
|
3
|
BIOASIS TECHNOLOGIES INC
|
Sep 22, 2020 03:24PM
|
Re: Gilead pays $21B for Immunomedics, a single cancer drug (newly approved) for metastic Triple Negative Breast Cancer
|
4
|
Zenith Epigenetics
|
Sep 22, 2020 07:55PM
|
Re: Proactive Article - new presentation on website
|
3
|
BIOASIS TECHNOLOGIES INC
|
Sep 23, 2020 05:25AM
|
Re: Proactive Article - new presentation on website
|
3
|
BIOASIS TECHNOLOGIES INC
|
Sep 23, 2020 08:55AM
|
Re: Proactive Article - new presentation on website
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 23, 2020 10:40AM
|
Re: Don's latest presentation - Pfizer's SGLT2 is Steglatro (Ertugliflozin)
|
6
|
Resverlogix Corp.
|
Sep 24, 2020 08:54AM
|
Re: Presentation up on YouTube
|
4
|
Resverlogix Corp.
|
Sep 24, 2020 10:55AM
|